Biotechnology Ultrasector Mutual Fund Forward View

BIPSX Fund  USD 39.43  0.44  1.13%   
Naive Prediction is applied to Biotechnology Ultrasector Profund's daily closing prices, and the resulting forecast is presented with accuracy metrics. Wide deviation between fitted and observed values suggests the model's assumptions may not match current market conditions. The Naive Prediction model projects Biotechnology Ultrasector at 39.07 for the next trading day, below the most recent closing price. This Naive Prediction output is provided as analytical reference and does not constitute a trading recommendation.
A naive forecasting model for Biotechnology Ultrasector is a special case of the moving average where the smoothing period is one. The forecast for Biotechnology Ultrasector Profund on a given trading day is simply the observed closing price of the previous period. Because it uses only a single lag, this model is limited to one-period-ahead forecasts.

Naive Prediction Price Forecast For the 9th of May

Over a 90-day horizon, the Naive Prediction model forecasts Biotechnology Ultrasector at 39.07 for the next trading day, with a mean absolute deviation of 0.80 , mean absolute percentage error of 0.02 , and sum of absolute errors of 48.56 .
This represents a tight forecast with good short-term tracking of Biotechnology Ultrasector's price movement. This output is intended for short-term analytical reference.

Mutual Fund Forecast Pattern

Backtest Biotechnology Ultrasector  Biotechnology Ultrasector Price Prediction  Research Analysis  

Forecasted Value

Biotechnology Ultrasector's next-session forecast estimates practical downside and upside boundaries based on the model's historical fit. The current forecast range spans downside near 36.32 and upside near 41.82. The wide range indicates elevated uncertainty in short-term projections.
Market Value
39.43
39.07
Expected Value
41.82

Model Predictive Factors

The table below summarizes the Naive Prediction model's error metrics for Biotechnology Ultrasector mutual fund. Lower MAD and MAPE values indicate tighter forecast accuracy. AIC measures relative model quality — lower values indicate less information loss and a better-fitting model. A large Bias suggests systematic over- or under-prediction.
AICAkaike Information Criteria118.2324
BiasArithmetic mean of the errors None
MADMean absolute deviation0.7961
MAPEMean absolute percentage error0.0216
SAESum of the absolute errors48.5647
The naive model produces a tight forecast range but offers no smoothing of noise or trend detection. It serves primarily as a baseline benchmark — if a more complex model cannot outperform the naive forecast, it may indicate that Biotechnology Ultrasector price movements are largely random over the selected horizon.

Other Forecasting Options for Biotechnology Ultrasector

The distribution of Biotechnology Ultrasector's daily returns is typically non-normal, with fatter tails than a Gaussian model predicts. This reveals hidden support and resistance zones in Biotechnology Ultrasector's chart that simple price charts miss.

Biotechnology Ultrasector Comparable Funds

These peer funds are related to Biotechnology Ultrasector and help frame its category context. Peer review is strongest when it focuses on NAV trend, discount or premium to NAV, yield, and fee burden. A fund that looks different from peers may simply be following a distinct exposure or payout strategy. Taken together, these peers help define a more relevant comparison frame for Biotechnology Ultrasector.
 Risk & Return  Correlation

Biotechnology Ultrasector Market Strength Events

Market strength indicators for Biotechnology Ultrasector mutual fund provide a framework for assessing security responsiveness. A rising Accumulation/Distribution line alongside rising price confirms institutional buying interest in Biotechnology Ultrasector.

Biotechnology Ultrasector Risk Indicators

Assessing Biotechnology Ultrasector's risk indicators is a structured way to evaluate the risk-return trade-off for biotechnology mutual fund. The level of risk embedded in Biotechnology Ultrasector's feeds directly into exposure calibration.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.